JP2005533789A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533789A5
JP2005533789A5 JP2004513217A JP2004513217A JP2005533789A5 JP 2005533789 A5 JP2005533789 A5 JP 2005533789A5 JP 2004513217 A JP2004513217 A JP 2004513217A JP 2004513217 A JP2004513217 A JP 2004513217A JP 2005533789 A5 JP2005533789 A5 JP 2005533789A5
Authority
JP
Japan
Prior art keywords
mono
poly
cyclic
substituents
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004513217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533789A (ja
JP4718172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/018262 external-priority patent/WO2003106381A2/en
Publication of JP2005533789A publication Critical patent/JP2005533789A/ja
Publication of JP2005533789A5 publication Critical patent/JP2005533789A5/ja
Application granted granted Critical
Publication of JP4718172B2 publication Critical patent/JP4718172B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004513217A 2002-06-12 2003-06-11 ヒトａｄａｍ−１０インヒビター Expired - Fee Related JP4718172B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38832602P 2002-06-12 2002-06-12
US60/388,326 2002-06-12
PCT/US2003/018262 WO2003106381A2 (en) 2002-06-12 2003-06-11 Human adam-10 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010142096A Division JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトａｄａｍ−１０インヒビター

Publications (3)

Publication Number Publication Date
JP2005533789A JP2005533789A (ja) 2005-11-10
JP2005533789A5 true JP2005533789A5 (enExample) 2011-02-24
JP4718172B2 JP4718172B2 (ja) 2011-07-06

Family

ID=29736461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004513217A Expired - Fee Related JP4718172B2 (ja) 2002-06-12 2003-06-11 ヒトａｄａｍ−１０インヒビター
JP2010142096A Pending JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトａｄａｍ−１０インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010142096A Pending JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトａｄａｍ−１０インヒビター

Country Status (7)

Country Link
US (5) US7629341B2 (enExample)
EP (3) EP2428509A1 (enExample)
JP (2) JP4718172B2 (enExample)
AU (2) AU2003237532B2 (enExample)
CA (1) CA2485346C (enExample)
ES (1) ES2425013T3 (enExample)
WO (1) WO2003106381A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517884B2 (en) * 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7629341B2 (en) 2002-06-12 2009-12-08 Symphony Evolution, Inc. Human ADAM-10 inhibitors
EP1613269B1 (en) 2003-04-04 2015-02-25 Incyte Corporation Compositions, methods and kits relating to her-2 cleavage
EP1623995A1 (en) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibitors of L1 and ADAM10 for the treatment of carcinomas
DK1805158T3 (en) 2004-10-29 2018-08-06 Kalypsys Inc SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR
US20070190079A1 (en) * 2004-10-29 2007-08-16 Kalypsys, Inc. Methods for the selective modulation of ppar
CA2604883A1 (en) * 2005-04-07 2006-10-19 Albert Lai Adam10 in cancer diagnosis, detection and treatment
US7863276B2 (en) * 2005-10-25 2011-01-04 Kalypsys, Inc Salts of modulators of PPAR and methods of treating metabolic disorders
WO2007084488A2 (en) 2006-01-13 2007-07-26 Vanderbilt University Adam10 and its uses related to infection
CN100506804C (zh) * 2006-01-26 2009-07-01 于学敏 羟苯磺酸烷基吡嗪药物及其制备方法和应用
US20070249519A1 (en) * 2006-04-20 2007-10-25 Kalypsys, Inc. Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
TW200745059A (en) * 2006-05-16 2007-12-16 Kalypsys Inc Sulfonyl-substituted bicyclic compounds as modulators of PPAR
WO2008091863A1 (en) * 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
WO2009052200A2 (en) * 2007-10-16 2009-04-23 Symphony Evolution, Inc. Human adam-10 inhibitors
EP2344453B1 (en) 2008-10-09 2016-12-28 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
CN102639134A (zh) * 2009-10-01 2012-08-15 和谐进化股份有限公司 使用基质金属蛋白酶-2抑制剂治疗动脉瘤样扩张、血管壁薄弱、特别是腹主动脉瘤和胸主动脉瘤的方法
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
JP5888667B2 (ja) * 2010-04-30 2016-03-22 国立大学法人名古屋大学 Ａｄａｍ作用阻害物質のスクリーニング方法、仮足の保持方法、仮足保持剤、仮足の制御物質のスクリーニング方法、及びａｄａｍ作用阻害剤
EP2637679A4 (en) 2010-11-09 2015-09-23 Univ Chicago ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASES AND THERAPEUTICS
WO2014028334A1 (en) * 2012-08-11 2014-02-20 Symphony Evolution, Inc. Selective mmp inhibitors
US20170038382A1 (en) * 2014-01-24 2017-02-09 Ntercept, Llc Methods and compositions for immune dis-inhibition
CN106999550B (zh) 2014-10-03 2023-02-28 纳米提克斯有限责任公司 用于抑制可溶生物分子的生物活性的组合物以及方法
CN116999396A (zh) 2015-07-29 2023-11-07 纳米提克斯有限责任公司 用于清除可溶性生物分子的模块化组合物及其相关方法
IL299915A (en) 2017-01-04 2023-03-01 Nanotics Llc Methods for assembling cleaning particles
CN108947850B (zh) * 2018-07-23 2021-05-18 蚌埠中实化学技术有限公司 一种3,4,5-三氟苯胺的制备方法
JP7754723B2 (ja) 2019-05-14 2025-10-15 ウェアウルフ セラピューティクス， インコーポレイテッド 分離部分及びその使用方法
BR112022009110A2 (pt) 2019-11-14 2022-07-26 Werewolf Therapeutics Inc Polipeptídeos de citocina ativáveis e métodos de uso destes
CN113563235B (zh) * 2021-07-28 2023-04-11 上海毕得医药科技股份有限公司 一种3-(卤代苯氧基)苯磺酰氯衍生物的合成方法
US20250177333A1 (en) * 2022-03-08 2025-06-05 Nova Southeastern University Method for treating rheumatoid arthritis (ra) using an enzyme-and substrate selective exosite inhibitor of a disintegrin and metalloprotease 10 (adam10)

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1016245A (en) 1962-11-06 1966-01-05 Ici Ltd Manufacture of polysulphones
US4213775A (en) * 1977-07-28 1980-07-22 Ube Industries, Ltd. Diphenyl ether derivatives and herbicidal compositions containing the same
DE3107700A1 (de) * 1981-02-28 1982-09-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von aromatischen sulfohalogeniden
EP0594590B1 (en) 1990-03-01 1995-09-06 The Upjohn Company Ruminal bacterium for preventing acute lactic acidosis
DE4015834A1 (de) * 1990-05-17 1991-11-21 Bayer Ag Phenoxyphenylsulfonylverbindungen
US5215549A (en) 1991-05-08 1993-06-01 Mobil Oil Corporation Thioester derived hindered phenols and aryl-amines as antioxidant and antiwear additives
DE4327026A1 (de) 1993-08-12 1995-02-16 Bayer Ag Arylsulfonyloxyphosphonsäurederivate
PT821671E (pt) 1995-04-20 2001-04-30 Pfizer Derivados do acido arilsulfonil hidroxamico como inibidores de mmp e tnf
JP3837761B2 (ja) * 1995-08-04 2006-10-25 住友精化株式会社 ハロベンゼンスルホニルクロリド類の製造方法
DE19537334A1 (de) 1995-10-09 1997-04-10 Hoechst Ag Antiadhäsive Piperidin- und Pyrrolidin-Carbonsäuren
AU725831C (en) * 1995-12-08 2002-10-17 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
US5753653A (en) * 1995-12-08 1998-05-19 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
IL128663A0 (en) 1996-08-28 2000-01-31 Procter & Gamble 1,4-heterocyclic metalloprotease inhibitors
CA2263883C (en) 1996-08-29 2003-07-08 The Regents Of The University Of California Kuz, a novel family of metalloproteases
WO1998027069A1 (en) 1996-12-17 1998-06-25 Fujisawa Pharmaceutical Co., Ltd. Piperazine compounds as inhibitors of mmp or tnf
EP0958287B2 (en) 1997-01-23 2008-04-09 F. Hoffmann-La Roche Ag Sulfamide-metalloprotease inhibitors
TR199901926T2 (xx) 1997-02-11 1999-12-21 Pfizer Inc. Arils�lfonil hidroksamik asit t�revleri
KR20010005940A (ko) * 1997-04-01 2001-01-15 아구론 파마슈티컬스, 인크. 메탈로프로테이나제 억제제를 포함하는 약제학적 조성물 및 이의 약제학적 용도
US5922546A (en) 1997-08-25 1999-07-13 Smithkline Beecham Corporation Human disintegrin metalloprotease KUZ gene
JP4327915B2 (ja) * 1998-03-30 2009-09-09 株式会社デ・ウエスタン・セラピテクス研究所 スルフォンアミド誘導体
GT199900044A (es) * 1998-04-10 2000-09-14 Procedimientos para preparar haluros de fenoxifenilsulfonilo.
EP1077978A1 (en) 1998-05-14 2001-02-28 Du Pont Pharmaceuticals Company Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
DE69925840T2 (de) 1998-08-12 2006-05-04 Pfizer Products Inc., Groton Tace inhibitoren
US6509337B1 (en) 1998-09-17 2003-01-21 Pfizer Inc. Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
US6225311B1 (en) 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
AR035313A1 (es) 1999-01-27 2004-05-12 Wyeth Corp Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
JP2000247975A (ja) 1999-02-25 2000-09-12 Nissan Chem Ind Ltd ヘテロ環縮合ピリミジノン誘導体及びそれらを含む除草剤
US6387901B1 (en) 1999-07-06 2002-05-14 Pfizer Inc Alkyne containing metalloproteinase inhibitors
EP1081137A1 (en) 1999-08-12 2001-03-07 Pfizer Products Inc. Selective inhibitors of aggrecanase in osteoarthritis treatment
WO2001055112A1 (en) 2000-01-27 2001-08-02 American Cyanamid Company Method for preparing alpha-sulfonyl hydroxamic acid derivatives
US6664291B2 (en) * 2000-03-31 2003-12-16 Pfizer, Inc. Malonamic acids and derivatives thereof as thyroid receptor ligands
JP4635162B2 (ja) * 2000-04-27 2011-02-16 独立行政法人理化学研究所 芳香族ジアミンの製造方法及び芳香族ジアミン化合物
WO2002067866A2 (en) 2001-02-27 2002-09-06 Axys Pharmaceuticals, Inc. Piperazine derivatives as metalloprotease inhibitors
CA2357110A1 (en) 2001-04-11 2002-10-11 American Cyanamid Company Method for the treatment of polycystic kidney disease
WO2002088115A1 (en) 2001-04-26 2002-11-07 Kolon Ind. Inc. Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
US6399823B1 (en) * 2001-04-30 2002-06-04 General Electric Company Method for producing phosgene
CN1610661A (zh) 2001-11-01 2005-04-27 惠氏控股公司 用作基质金属蛋白酶和tace的抑制剂的丙二烯芳基磺酰胺异羟肟酸
CN1173960C (zh) 2001-12-06 2004-11-03 中国人民解放军军事医学科学院毒物药物研究所 取代六元氮杂环类化合物及其作为神经调节剂的用途
US7498358B2 (en) * 2001-12-14 2009-03-03 Exelixis, Inc. Human ADAM-10 inhibitors
US7504537B2 (en) 2001-12-27 2009-03-17 Dainippon Sumitomo Pharma Co., Ltd. Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
US7488754B2 (en) 2002-04-05 2009-02-10 Wyeth Method for the treatment of polycystic kidney disease
US7629341B2 (en) 2002-06-12 2009-12-08 Symphony Evolution, Inc. Human ADAM-10 inhibitors
MXPA05001603A (es) 2002-08-13 2005-04-25 Warner Lambert Co Derivados monociclicos como inhibidores de metaloproteinasa de matriz.
EP1400244A1 (en) 2002-09-17 2004-03-24 Warner-Lambert Company LLC New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
ATE429228T1 (de) 2003-02-14 2009-05-15 Serono Lab Derivate von piperazine-2-carboxamide
JP2006517960A (ja) 2003-02-18 2006-08-03 ファイザー インコーポレイテッド Ｃ型肝炎ウイルスの阻害剤、それを使用する組成物および治療法
US7563781B2 (en) 2005-01-14 2009-07-21 Janssen Pharmaceutica Nv Triazolopyrimidine derivatives
EP1940805A4 (en) 2005-08-26 2009-11-11 Methylgene Inc BENZODIAZEPIN AND BENZOPIPERAZINANALOGA AS INHIBITORS OF HISTONDEACETYLASE
EP1937632A1 (en) 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds

Similar Documents

Publication Publication Date Title
JP2005533789A5 (enExample)
JP2006505543A5 (enExample)
JP2012510502A5 (enExample)
JP2010511626A5 (enExample)
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
JP2003521537A5 (enExample)
JP2007501809A5 (enExample)
JP2007503202A5 (enExample)
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
JP2006151984A5 (enExample)
JP2014516360A5 (enExample)
JP2005523922A5 (enExample)
JP2005501904A5 (enExample)
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
JP2010501478A5 (enExample)
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
JP2005526097A5 (enExample)
AR050518A1 (es) Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv
AR064318A1 (es) Compuesto y composicion derivada de aril sulfamida, uso del compuesto y proceso para la preparacion del compuesto
JP2020502116A5 (enExample)
RU2401267C2 (ru) Замещенные производные бензохинолизина
JP2004518658A5 (enExample)
ATE394379T1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
AR065297A1 (es) Formulaciones biodisponibles de compuestos heterociclicos
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина